Healthcare

Pinnacle Food Reports Laboratory-Scale Astaxanthin Extraction in Microalgae Programme

Pinnacle Food Group Limited says its Vancouver research team has extracted astaxanthin at laboratory scale after progressing through cultivation and stress-induction stages.

Published:
Reading Time
2 min

Pinnacle Food Group Limited (NASDAQ:PFAI) said its Canadian subsidiary, Pinnacle Food Inc., has completed astaxanthin extraction at laboratory scale as part of its Haematococcus pluvialis research programme. The work was conducted in-house at the company’s Vancouver laboratory and represents an early-stage research milestone.

#Research workflow reaches extraction stage

The programme has moved through several stages, beginning with algal strain screening and followed by three-stage culture expansion. The company then carried out stress induction and astaxanthin accumulation before extracting the compound from the cultivated biomass.

Cultivation used a 500-liter photobioreactor. The subsequent extraction was performed at laboratory scale using a process developed in-house by Pinnacle Food.

#Astaxanthin research remains at laboratory scale

Astaxanthin is a naturally occurring carotenoid, while Haematococcus pluvialis is a microalga widely studied as a source of the compound. Pinnacle Food said its current results remain limited to laboratory scale and that additional work is needed before commercial viability can be assessed.

The company said there is no assurance that the research will lead to a commercially viable process or product. Laboratory results may not be replicated or improved in later experiments or at larger scales, and the programme still faces uncertainties involving yields, purity, production costs and product quality.

#Planned work and identified risks

Pinnacle Food intends to continue work on process optimisation and assess whether the programme can be scaled up. Chief Executive Officer Jiulong You described the completed workflow as an early-stage milestone and said the company would continue evaluating those areas within its microalgae biomanufacturing research.

The company also identified technical challenges related to cultivation, extraction, process development and scale-up. Other risks include intellectual property ownership, protection and freedom-to-operate; obtaining and maintaining required regulatory approvals; funding availability; competition; changes in market demand and pricing; and broader economic and industry conditions.

#About Pinnacle Food Group

Pinnacle Food Group is a technology-driven company operating at the intersection of smart farming and bioengineering. The company says its activities include controlled-environment agricultural technologies, precision fermentation, synthetic biology and related engineering capabilities. Its shares trade on NASDAQ under the ticker PFAI.

#Key Takeaways

  • Pinnacle Food’s Canadian subsidiary completed astaxanthin extraction at laboratory scale.
  • The programme uses Haematococcus pluvialis cultivated in a 500-liter photobioreactor.
  • The workflow has advanced through strain screening, culture expansion, stress induction, accumulation and extraction.
  • The results remain at laboratory scale, with further work required before commercial viability can be assessed.
  • The company plans further process optimisation and evaluation of scale-up feasibility, while identifying technical, regulatory, funding and market risks.

Original source: Read original article

Frequently Asked Questions